Skip to main content
HeartCited

NMN (Nicotinamide Mononucleotide) para Arterial Stiffness

C

Single RCT showed improved pulse wave velocity in middle-aged adults. NAD+ restoration mechanism is compelling. Larger cardiovascular-specific trials are ongoing.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnmn\u0026condition\u003Darterial\u002Dstiffness'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Conclusión

Single RCT showed improved pulse wave velocity in middle-aged adults. NAD+ restoration mechanism is compelling. Larger cardiovascular-specific trials are ongoing.

Key Statistics

2

Estudios

100

Participantes

Positive

C

Calificación

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
250-500 mg/day
antiagingprotocols:
500-1,000 mg/day

Límite superior: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e

Mejor momento para tomar: Morning on empty stomach or with light meal; sublingual for enhanced bioavailability

Safety & Side Effects

Efectos secundarios reportados

  • Generally well-tolerated
  • Mild gastrointestinal discomfort
  • Flushing (rare)
  • Headache (rare)

Interacciones conocidas

  • May interact with NAD+-dependent medications
  • Theoretical interaction with diabetes medications (may affect glucose metabolism)

Ingesta máxima tolerable: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does NMN (Nicotinamide Mononucleotide) help with Arterial Stiffness?
Based on 2 studies with 100 participants, there is limited but promising evidence that NMN (Nicotinamide Mononucleotide) may support Arterial Stiffness management. Our evidence grade is C (Some Evidence).
How much NMN (Nicotinamide Mononucleotide) should I take for Arterial Stiffness?
Studies have used various dosages. A commonly studied range is 250-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of NMN (Nicotinamide Mononucleotide)?
Reported side effects may include Generally well-tolerated, Mild gastrointestinal discomfort, Flushing (rare), Headache (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for NMN (Nicotinamide Mononucleotide) and Arterial Stiffness?
We rate the evidence as Grade C (Some Evidence). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

Related Evidence

Otros ingredientes para Arterial Stiffness

NMN (Nicotinamide Mononucleotide) para otras condiciones

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.